Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 569071, 9 pages
http://dx.doi.org/10.1155/2015/569071
Research Article

Quantitative Image Analysis of Epithelial and Stromal Area in Histological Sections of Colorectal Cancer: An Emerging Diagnostic Tool

1Department of Pathophysiology and Allergy Research, Medical University of Vienna, 1090 Vienna, Austria
2TissueGnostics GmbH, 1020 Vienna, Austria
3Clinical Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria
4Seewald Solutions, 4616 Weisskirchen/Traun, Austria
5Department of Clinical Pharmacy and Diagnostics, University of Vienna, 1090 Vienna, Austria
6Faculty of Automatic Control and Computer Engineering, “Gheorghe Asachi” Technical University of Iasi, 700050 Iasi, Romania

Received 23 July 2015; Revised 28 September 2015; Accepted 30 September 2015

Academic Editor: Hung-Ming Lam

Copyright © 2015 R. Rogojanu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Sawyers, “The cancer biomarker problem,” Nature, vol. 452, no. 7187, pp. 548–552, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Ogino, P. Lochhead, A. T. Chan et al., “Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease,” Modern Pathology, vol. 26, no. 4, pp. 465–484, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. E. J. A. Morris, N. J. Maughan, D. Forman, and P. Quirke, “Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology,” Gut, vol. 56, no. 10, pp. 1419–1425, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Jass, “Molecular heterogeneity of colorectal cancer: implications for cancer control,” Surgical Oncology, vol. 16, supplement 1, pp. S7–S9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Zlobec and A. Lugli, “Prognostic and predictive factors in colorectal cancer,” Postgraduate Medical Journal, vol. 84, no. 994, pp. 403–411, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Allen and J. Louise Jones, “Jekyll and Hyde: the role of the microenvironment on the progression of cancer,” Journal of Pathology, vol. 223, no. 2, pp. 162–176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Karamitopoulou, I. Zlobec, I. Panayiotides et al., “Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer,” Human Pathology, vol. 42, no. 12, pp. 1888–1896, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Sund and R. Kalluri, “Tumor stroma derived biomarkers in cancer,” Cancer and Metastasis Reviews, vol. 28, no. 1-2, pp. 177–183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Scurr, A. Gallimore, and A. Godkin, “T cell subsets and colorectal cancer: discerning the good from the bad,” Cellular Immunology, vol. 279, no. 1, pp. 21–24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Q.-W. Zhang, L. Liu, C.-Y. Gong et al., “Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature,” PLoS ONE, vol. 7, no. 12, Article ID e50946, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Betge, M. J. Pollheimer, R. A. Lindtner et al., “Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting,” Cancer, vol. 118, no. 3, pp. 628–638, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. N. P. West, M. Dattani, P. McShane et al., “The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients,” British Journal of Cancer, vol. 102, no. 10, pp. 1519–1523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Huijbers, R. A. E. M. Tollenaar, G. W. V. Pelt et al., “The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the victor trial,” Annals of Oncology, vol. 24, no. 1, Article ID mds246, pp. 179–185, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. E. M. de Kruijf, J. G. H. van Nes, C. J. H. van de Velde et al., “Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients,” Breast Cancer Research and Treatment, vol. 125, no. 3, pp. 687–696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. E. F. W. Courrech Staal, V. T. H. B. M. Smit, M.-L. F. Van Velthuysen et al., “Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies,” European Journal of Cancer, vol. 47, no. 3, pp. 375–382, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. A. Rubio, “Cell proliferation at the leading invasive front of colonic carcinomas. Preliminary observations,” Anticancer Research, vol. 26, no. 3, pp. 2275–2278, 2006. View at Google Scholar · View at Scopus
  17. A. Jung, M. Schrauder, U. Oswald et al., “The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear β-catenin, cyclin D1, and p16INK4A and is a region of low proliferation,” The American Journal of Pathology, vol. 159, no. 5, pp. 1613–1617, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Ponz de Leon, L. Roncucci, P. Di Donato et al., “Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel,” Cancer Research, vol. 48, no. 14, pp. 4121–4126, 1988. View at Google Scholar · View at Scopus
  19. N. Otsu, “A threshold selection method from gray-level histogram,” IEEE Transactions on Systems, Man and Cybernetics, vol. 9, no. 1, pp. 62–66, 1979. View at Publisher · View at Google Scholar · View at Scopus
  20. R. C. Gonzales and R. E. Woods, Digital Image Processing, Prentice-Hall, 3rd edition, 2007.
  21. V. Karantza, “Keratins in health and cancer: more than mere epithelial cell markers,” Oncogene, vol. 30, no. 2, pp. 127–138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Brabletz, F. Hlubek, S. Spaderna et al., “Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin,” Cells Tissues Organs, vol. 179, no. 1-2, pp. 56–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. S. B. Wilson and R. Emerson, “Spike detection: a review and comparison of algorithms,” Clinical Neurophysiology, vol. 113, no. 12, pp. 1873–1881, 2002. View at Publisher · View at Google Scholar
  24. C. J. van Rijsbergen, Information Retrieval, Butterworths, London, UK, 2nd edition, 1979.
  25. C. Smochina, V. Manta, and W. Kropatsch, “Crypts detection in microscopic images using hierarchical structures,” Pattern Recognition Letters, vol. 34, no. 8, pp. 934–941, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. P. Sleeman, G. Christofori, R. Fodde et al., “Concepts of metastasis in flux: the stromal progression model,” Seminars in Cancer Biology, vol. 22, no. 3, pp. 174–186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Lugli, E. Karamitopoulou, and I. Zlobec, “Tumour budding: a promising parameter in colorectal cancer,” British Journal of Cancer, vol. 106, no. 11, pp. 1713–1717, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. R. Trusheim, E. R. Berndt, and F. L. Douglas, “Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers,” Nature Reviews Drug Discovery, vol. 6, no. 4, pp. 287–293, 2007. View at Publisher · View at Google Scholar · View at Scopus